<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?xml-stylesheet href="drugsmodel.xsl" type="text/xsl" ?>
<model xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="0.6" xsi:noNamespaceSchemaLocation="drug.xsd">
  <!-- Drug History-->
  <history>
    <creator>
      <name>Nathalie Rohrbach et Pierre Destraz</name>
      <institution>HEIG-VD</institution>
      <email>nathalie.rohrbach@heig-vd.ch</email>
      <date>2014-06-06</date>
      <comments>
          <comment lang="fr">
            Basé sur le modèle de population pharmacogénétique par M Arab-Alameddine,
            J Di Iulio, T Buclin, M Rotger, R Lubomirov, M Cavassini, A Fayet,
            LA Décosterd, CB Eap, J Biollaz, A Telenti and C Csajka; the Swiss HIV Cohort Study.
            Cet article visait à identifier les principales covariables pour mesurer la clearance
            des patients atteints de VIH.
          </comment>
          <comment lang="en">
            Pharmacogenetics-Based Population, pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals.
            This article's aim was to seek a general approach combining genetic and demographic covariates.
          </comment>
        </comments>
    </creator>
    <revisions>
	<revision>
	    <name>Robert Hooper</name>
      <institution>HEIG-VD // REDS</institution>
      <email>robert.hooper@heig-vd.ch</email>
      <date>2014-07-15</date>
      <comments/>
	</revision>
	<revision>
        <name>Robert Hooper</name>
      <institution>HEIG-VD // REDS</institution>
      <email>robert.hooper@heig-vd.ch</email>
      <date>2014-07-30</date>
      <comments/>
    </revision>
	<revision>
        <name>Severine Petitprez</name>
      <institution>CHUV</institution>
      <email>severine.petitprez@chuv.ch</email>
      <date>2016-05-30</date>
      <comments/>
    </revision>
    <revision>
        <name>Sylvain Goutelle</name>
      <institution>CHUV</institution>
      <email>sylvain.goutelle@chuv.ch</email>
      <date>2017-08-30</date>
      <comments><comment lang="en">
      Age range : 30-73
      Weight range : 44-101
      Disease. : HIV infection
      </comment></comments>
    </revision>
    <revision>
        <name>Yann Thoma</name>
      <institution>HEIG-VD</institution>
      <email>yann.thoma@heig-vd.ch</email>
      <date>2017-09-08</date>
      <comments><comment lang="en">
      Corrected the CL script
    </comment></comments>
    </revision>
    </revisions>

  </history>

  <!-- Drug data -->
  <drug>
    <!--Drug description-->
    <head>
      <atc>J05AG03</atc>
      <drugid>efavirenz</drugid>
      <drugmodelid>ch.heig-vd.ezechiel.efavirenz</drugmodelid>
      <pkmodelid>ezechiel.model.linear.1comp.extra.clv</pkmodelid>
      <drugnames>
        <name lang="en">Efavirenz</name>
        <name lang="fr">Efavirenz</name>
      </drugnames>
      <domainnames>
        <name lang="en">Adults</name>
        <name lang="fr">Adultes</name>
      </domainnames>
      <studynames>
        <name lang="fr">Basé sur le modèle de population pharmacogénétique  par M Arab-Alameddine, J Di Iulio, T Buclin, M Rotger, R Lubomirov, M Cavassini, A Fayet, LA Décosterd, CB Eap, J Biollaz, A Telenti and C Csajka; the Swiss HIV Cohort Study</name>
        <name lang="en">Pharmacogenetics-Based Population, Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals</name>
      </studynames>
      <references>
          <reference type='bibtex'>@article{arab-alameddine_pharmacogenetics-based_2009,
	title = {Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in {HIV}-1-Infected Individuals},
	volume = {85},
	issn = {0009-9236, 1532-6535},
	url = {http://www.nature.com/doifinder/10.1038/clpt.2008.271},
	doi = {10.1038/clpt.2008.271},
	number = {5},
	urldate = {2014-10-23},
	journal = {Clinical Pharmacology \%26\%2338; Therapeutics},
	author = {Arab-Alameddine, M and Di Iulio, J and Buclin, T and Rotger, M and Lubomirov, R and Cavassini, M and Fayet, A and Décosterd, La and Eap, Cb and Biollaz, J and Telenti, A and Csajka, C},
	month = may,
	year = {2009},
	pages = {485--494},
	file = {2011_Arab_alameddine_Efavirenz.pdf:/home/rob/.zotero/zotero/iv5zqg2p.default/zotero/storage/6DZP9D4E/2011_Arab_alameddine_Efavirenz.pdf:application/pdf}
}
	</reference>
	</references>
	<descs>
        <desc lang="en">Description of the drug</desc>
        <desc lang="fr">Description du médicament</desc>
      </descs>
      <brands>
        <brand>Efavirenz</brand><!-- No brands cited in the article-->
      </brands>
      <comments>
          <comment lang="fr">
            La population test est atteinte du VIH.
            L'âge de la population d'étude se situe entre (30-73) ans et concerne donc les adultes.
          </comment>
          <comment lang="en">
            HIV infected patients.
            Age of the population study is between (30-73) years and therefore concerns adults.
          </comment>
        </comments>
    </head>


    <!-- Drug adme and intake-->
    <adme>
      <intake>extra</intake>
      <distribution>1</distribution>
      <elimination>linear</elimination>
      <comments>
          <comment lang="fr">
            Ce médicament se prend par voie orale.
            Il arrive directement dans l'estomac et on considère donc un modèle à un compartiment.
            Son élimination se fait principalement par le foie des patients et est considérée comme linéaire.
          </comment>
          <comment lang="en">
            This medicine is administred only orally.
            A one-compartment model with first-order absorption from the gastrointestinal tract
            fitted the data appropriately.
            Its elimination is mostly done by the patients' liver and is considered linear.
          </comment>
        </comments>

    </adme>

    <!-- Drug half-life -->

    <halflife>
      <unit>h</unit>
      <value>50</value>
      <multiplier>10</multiplier>
      <comments/>
    </halflife>

    <!-- Drug units and conversions-->
    <conversions>
      <units>
        <concentration>ug/l</concentration>
        <result>ug/l</result>
      </units>
      <factors>
        <concentration>0</concentration> <!--unknown-->
        <result>0</result> <!--unknown-->
      </factors>
      <molarmass>0</molarmass> <!--unknown-->
      <comments>
          <comment lang="fr">
            En ng/ml dans l'article donné.
          </comment>
          <comment lang="en">
            In ng/ml in the given article.
          </comment>
        </comments>
    </conversions>

    <!-- Drug dosages -->
    <dosages>
      <doses default="600" unit="mg" any="false">
        <dose>200</dose>
        <dose>400</dose>
        <dose>600</dose>
        <dose>800</dose>
      </doses>

      <intervals default="24" unit="h" any="false">
        <interval>12</interval>
        <interval>24</interval>
      </intervals>
      <infusions default="0" unit="min" any="false"/>
      <comments>
          <comment lang="en">
            Standard dose for this study was 600mg/day.
            The dosage is required to be reduced to 200 mg/day of EFV in individuals
            with impaired CYP2B6 function
          </comment>
          <comment lang="fr">Pour l'étude, la dose standard était de 600mg/jour.
          Cette dose doit être réduite à 200mg/jour pour les patients atteints
          d'une altération de la fonction de l'enzyme CYP2B6
        </comment>
        </comments>
    </dosages>

    <!-- Drug targets-->
    <targets>
    </targets>

    <!-- Drug covariates -->
    <covariates>
      <covariate>
        <id>bodyweight</id>
        <names>
          <name lang="en">Body weight</name>
          <name lang="fr">Poids</name>
        </names>
        <descs>
          <desc lang="en">Body weight of the patient, in kilograms</desc>
          <desc lang="fr">Poids du patient, en kilogrammes</desc>
        </descs>
        <unit>kg</unit><!-- in kilograms -->
        <type>double</type>
        <defaultvalue>78</defaultvalue>
        <comments>
            <comment lang="en">
              The default value represents the study's subjects' median body weight.
              Pharmacogenetics fully accounted for ethnicity, leaving body weight as
              the only significant demographic factor influencing CL.
            </comment>
            <comment lang="fr">
              La valeur par défaut représente le poids médian des sujets de l'étude.
              Le poids est la seule covariable démographique significative car la
              pharmacogénétique prend déjà en compte les différences ethniques.
            </comment>
          </comments>
      </covariate>

      <covariate>
        <id>p</id>
        <names>
          <name lang="en">CYP2B6</name>
        </names>
        <descs>
          <desc lang="en">Enzyme CYP2B6</desc>
        </descs>
        <unit>--</unit> <!-- No unit for this value-->
        <type>double</type> <!-- Int for A solution but can be double for B and C solutions-->
        <defaultvalue>2</defaultvalue> <!-- For A solutions can be 0, 1, 2 or 3-->
        <comments>
            <comment lang="en">
              Number of functional alleles of an enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref, 3 = Het-GOF.
              Hom: homozygous. LOF: loss of function. Het: heterozygous. Ref: reference allele. GOF: Gain of function.
            </comment>
            <comment lang="fr">
              Nombre d'allèles fonctionnelles d'une enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref, 3 = Het-GOF.
              Hom: homozygote. LOF: perte de fonction. Het: hétérozygote. Ref: allèle de référence. GOF: Gain de fonction.
            </comment>
          </comments>
      </covariate>

      <covariate>
        <id>q</id>
        <names>
          <name lang="en">CYP2A6</name>
        </names>
        <descs>
          <desc lang="en">Enzyme CYP2A6</desc>
        </descs>
        <unit>--</unit> <!-- No unit for this value-->
        <type>double</type> <!-- Int for A solution but can be double for B and C solutions-->
        <defaultvalue>2</defaultvalue> <!-- For A solutions can be 0, 1, 2 or 3-->
        <comments>
            <comment lang="en">
              Number of functional alleles of an enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref
              Hom: homozygous. LOF: loss of function. Het: heterozygous. Ref: reference allele
            </comment>
            <comment lang="fr">
              Nombre d'allèles fonctionnelles d'une enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref
              Hom: homozygote. LOF: perte de fonction. Het: hétérozygote. Ref: allèle de référence.
            </comment>
          </comments>
      </covariate>

      <covariate>
        <id>r</id>
        <names>
          <name lang="en">CYP3A4</name>
        </names>
        <descs>
          <desc lang="en">Enzyme CYP3A4</desc>
        </descs>
        <unit>--</unit> <!-- No unit for this value-->
        <type>double</type> <!-- Int for A solution but can be double for B and C solutions-->
        <defaultvalue>2</defaultvalue> <!-- For A solutions can be 0, 1, 2 or 3-->
        <comments>
            <comment lang="en">
              Number of functional alleles of an enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref
              Hom: homozygous. LOF: loss of function. Het: heterozygous. Ref: reference allele. GOF
            </comment>
            <comment lang="fr">
              Nombre d'allèles fonctionnelles d'une enzyme: 0=Hom-LOF 1=Het-LOF, 2 = Hom-Ref
              Hom: homozygote. LOF: perte de fonction. Het: hétérozygote. Ref: allèle de référence.
            </comment>
          </comments>
      </covariate>
    </covariates>

    <!-- Drug error model -->
    <errormodel>
      <additive>0</additive>
      <proportional>0.308</proportional>
      <!-- means 30.8 % -->
      <comments>
          <comment lang="en">
            Residual intrapatient variability
          </comment>
          <comment lang="fr">
            Variance résiduelle intrapatient
          </comment>
        </comments>
    </errormodel>

    <!-- Drug parameters -->
    <parameters>
      <parameter>
        <id>CL</id>
        <unit>l/h</unit>
        <value>14.07</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.278</proportional> <!-- means 27.8 %-->
        </bsv>
        <min>0.001</min>
        <max>100000</max>
        <step>1</step>
        <comments>
            <comment lang="en">Calculate clearance for average weight and wild-tzype genotype, with Hom-REF genotypes for the three genes</comment>
          </comments>
      </parameter>

      <parameter>
        <id>V</id>
        <unit>l</unit>
        <value>332</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.0</proportional>
        </bsv>
        <min>0.1</min>
        <max>50000</max>
        <step>5</step>
        <comments>
          </comments>
      </parameter>

      <parameter>
        <id>Ka</id>
        <unit>h-1</unit>
        <value>0.6</value>
        <bsv>
          <additive>0.0</additive>
          <proportional>0.0</proportional>
        </bsv>
        <min>0.01</min>
        <max>10</max>
        <step>0.01</step>
        <comments>
          </comments>
      </parameter>

      <parameter>
        <id>F</id>
        <unit></unit>
        <value>1</value>
        <bsv>
          <additive>0</additive>
          <proportional>0</proportional>
        </bsv>
        <min>0.001</min>
        <max>1</max>
        <step>0.01</step>
        <comments>
            <comment lang="fr">
              Ce paramètre a dû être ajouté car la concentration était beaucoup trop élevée dans les graphiques Ezechiel. Doit être ajouté pour les prises extravasculaires
            </comment>
            <comment lang="en">
              This parameter had to be added as we have an extravascular case.
            </comment>
          </comments>
      </parameter>

    </parameters>

    <!-- Drug correlations -->
    <correlations>

    </correlations>

    <!-- Drug operations -->
    <operations>
      <operation>
        <parameter>CL</parameter>
        <formula><![CDATA[
theta1 = 1.3;
theta2 = 7.3;
theta3 = 0.7;
theta4 = 1.03;
theta5 = 0.7;

TVCL = theta1*(1+ theta5 * (covariate_bodyweight / 78)) + theta2 * Math.sqrt(covariate_p) + theta3 * Math.sqrt(covariate_q) + theta4* Math.sqrt(covariate_r);
return TVCL;
        ]]></formula>
        <comments>
          </comments>
      </operation>
    </operations>

    <!-- Drug general comments -->
    <comments/>

  </drug>
</model>
